secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAIA Biotechnology, Inc. (MAIA)
CIK:        0001878313
Form:       8-K
Filed at:   2024-02-14T23:59:59+00:00
Accession:  0001193125-24-036587
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MAIA enters into ATM agreement to sell up to $1.445M of common stock via H.C. Wainwright
--------------------------------------------------------------------------------

- ATM agreement with H.C. Wainwright to sell up to $1,445,000 of common stock.
- Wainwright will receive 3.0% commission on gross proceeds from each sale.
- Shares sold under existing effective shelf registration statement (Form S-3).
- Agreement terminates upon sale of all shares or by either party at any time.
- Company not obligated to sell any shares; may suspend solicitation at any time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1878313/000119312524036587/0001193125-24-036587-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1878313/000119312524036587/d756637d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-036587

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer